Israeli focused-ultrasound developer InSightec has received regulatory approval from the Australian and Taiwanese governments for the commercial distribution of its ExAblate 2000 MR-guided focused ultrasound (MRgFUS) system.
The incisionless surgery system is used for the treatment of uterine fibroids, according to the Haifa-based vendor.
By AuntMinnie.com staff writers
June 21, 2006
Related Reading
InSightec reports first North American MRgFUS patient, May 31, 2006
Image guidance evolves into imaging therapy, May 12, 2006
Rapid interleaved technique speeds MRgFUS fibroid treatment, May 2, 2006
InSightec completes ExAblate African-American enrollment, March 21, 2006
Copyright © 2006 AuntMinnie.com